Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)
NCT00144508
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
306
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
MRA (Tocilizumab)
OTHER:
current treatment
Sponsor
Chugai Pharmaceutical